These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

864 related articles for article (PubMed ID: 12388726)

  • 1. Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques.
    Stevceva L; Alvarez X; Lackner AA; Tryniszewska E; Kelsall B; Nacsa J; Tartaglia J; Strober W; Franchini G
    J Virol; 2002 Nov; 76(22):11659-76. PubMed ID: 12388726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
    Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
    J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
    Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
    J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.
    Benson J; Chougnet C; Robert-Guroff M; Montefiori D; Markham P; Shearer G; Gallo RC; Cranage M; Paoletti E; Limbach K; Venzon D; Tartaglia J; Franchini G
    J Virol; 1998 May; 72(5):4170-82. PubMed ID: 9557706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen.
    Hel Z; Tsai WP; Thornton A; Nacsa J; Giuliani L; Tryniszewska E; Poudyal M; Venzon D; Wang X; Altman J; Watkins DI; Lu W; von Gegerfelt A; Felber BK; Tartaglia J; Pavlakis GN; Franchini G
    J Immunol; 2001 Dec; 167(12):7180-91. PubMed ID: 11739541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen.
    Zhao J; Pinczewski J; Gómez-Román VR; Venzon D; Kalyanaraman VS; Markham PD; Aldrich K; Moake M; Montefiori DC; Lou Y; Pavlakis GN; Robert-Guroff M
    J Virol; 2003 Aug; 77(15):8354-65. PubMed ID: 12857905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.
    Hel Z; Nacsa J; Tryniszewska E; Tsai WP; Parks RW; Montefiori DC; Felber BK; Tartaglia J; Pavlakis GN; Franchini G
    J Immunol; 2002 Nov; 169(9):4778-87. PubMed ID: 12391187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.
    Almond N; Berry N; Stebbings R; Preston M; Ham C; Page M; Ferguson D; Rose N; Li B; Mee ET; Hassall M; Stahl-Hennig C; Athanasopoulos T; Papagatsias T; Herath S; Benlahrech A; Dickson G; Meiser A; Patterson S
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
    Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ
    Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal and systemic SIV-specific cytotoxic CD4
    Khanna M; Jackson RJ; Alcantara S; Amarasena TH; Li Z; Kelleher AD; Kent SJ; Ranasinghe C
    Sci Rep; 2019 Apr; 9(1):5661. PubMed ID: 30952887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a vaccine regimen composed of simian immunodeficiency virus DNA, rMVA, and viral particles administered to female rhesus macaques via four different mucosal routes.
    Manrique M; Kozlowski PA; Cobo-Molinos A; Wang SW; Wilson RL; Montefiori DC; Carville A; Aldovini A
    J Virol; 2013 Apr; 87(8):4738-50. PubMed ID: 23408627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Frequency of Vaccine-Induced T-Cell Responses Does Not Predict the Rate of Acquisition after Repeated Intrarectal SIVmac239 Challenges in
    Martins MA; Gonzalez-Nieto L; Shin YC; Domingues A; Gutman MJ; Maxwell HS; Magnani DM; Ricciardi MJ; Pedreño-Lopez N; Bailey VK; Altman JD; Parks CL; Allison DB; Ejima K; Rakasz EG; Capuano S; Desrosiers RC; Lifson JD; Watkins DI
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equivalent immunogenicity of the highly attenuated poxvirus-based ALVAC-SIV and NYVAC-SIV vaccine candidates in SIVmac251-infected macaques.
    Hel Z; Nacsa J; Tsai WP; Thornton A; Giuliani L; Tartaglia J; Franchini G
    Virology; 2002 Dec; 304(1):125-34. PubMed ID: 12490410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: potential role in vaccine efficacy.
    Leno M; Carter L; Venzon DJ; Romano J; Markham PD; Limbach K; Tartaglia J; Paoletti E; Benson J; Franchini G; Robert-Guroff M
    AIDS Res Hum Retroviruses; 1999 Mar; 15(5):461-70. PubMed ID: 10195756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques.
    Nacsa J; Radaelli A; Edghill-Smith Y; Venzon D; Tsai WP; Morghen Cde G; Panicali D; Tartaglia J; Franchini G
    Vaccine; 2004 Jan; 22(5-6):597-606. PubMed ID: 14741150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of Gag-specific CD8(+) T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques.
    Hel Z; Nacsa J; Kelsall B; Tsai WP; Letvin N; Parks RW; Tryniszewska E; Picker L; Lewis MG; Edghill-Smith Y; Moniuszko M; Pal R; Stevceva L; Altman JD; Allen TM; Watkins D; Torres JV; Berzofsky JA; Belyakov IM; Strober W; Franchini G
    J Virol; 2001 Dec; 75(23):11483-95. PubMed ID: 11689630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-secreting cells specific for simian immunodeficiency virus antigens in lymphoid and mucosal tissues of immunized macaques.
    Bergmeier LA; Mitchell EA; Hall G; Cranage MP; Cook N; Dennis M; Lehner T
    AIDS; 1998 Jul; 12(10):1139-47. PubMed ID: 9677162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge.
    Kwa S; Lai L; Gangadhara S; Siddiqui M; Pillai VB; Labranche C; Yu T; Moss B; Montefiori DC; Robinson HL; Kozlowski PA; Amara RR
    J Virol; 2014 Sep; 88(17):9579-89. PubMed ID: 24920805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.
    Lü X; Kiyono H; Lu D; Kawabata S; Torten J; Srinivasan S; Dailey PJ; McGhee JR; Lehner T; Miller CJ
    AIDS; 1998 Jan; 12(1):1-10. PubMed ID: 9456249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced immunity and protective efficacy against SIVmac251 intrarectal challenge following ad-SIV priming by multiple mucosal routes and gp120 boosting in MPL-SE.
    Pinczewski J; Zhao J; Malkevitch N; Patterson LJ; Aldrich K; Alvord WG; Robert-Guroff M
    Viral Immunol; 2005; 18(1):236-43. PubMed ID: 15802969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.